Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effects of Sonelokimab in Patients with Active Psoriatic Arthritis or Axial Spondyloarthritis

    Recruiting

    2 1 1
    Germany
  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Poland +1
  • Study on the Safety and Immune Response of Shingrix Vaccine in Patients with Psoriasis or Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Germany
  • Study on Morning vs. Evening Dosing of Tofacitinib for Patients with Rheumatoid or Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Estonia Germany Greece Hungary +4
  • Study of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark
  • Study on the Effect of Guselkumab for Treating Enthesitis in Patients with Psoriatic Arthritis Who Have Not Used Biologic DMARDs

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Reducing Immunosuppressive Drugs in Adults with Psoriatic Arthritis: Methotrexate Disodium, Abatacept, and Certolizumab Pegol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Germany Italy
  • Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Germany Italy Poland +2
  • A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Estonia Finland France +10